Michael Berendt has been appointed chief executive officer of Bioniche Life Sciences Inc. Dr. Berendt replaces Graeme McRae, who plans to retire and assume the role of founder and chairman emeritus of the board of directors.   Dr. Berendt has held positions of increasing responsibility in the U.S. research departments at Pfizer and Bayer Corp. He also served as managing director of the Life Sciences Sector of AEA Investors, and managing director of Research Corporation Technologies. In 2006, he ...